Breaking News
Sort by:
Top Post
NHS Slashes Longest Elective and Cancer Patient Waiting Lists
The number of people waiting over 18 months for NHS care has fallen again despite […]
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia
BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration […]
Lantern Pharma Announces First Patient Dosed in Study for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer
Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning […]
MIMETAS and Astellas Enter into Strategic Partnership
MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]
First New Life-extending NHS Treatment for Incurable Cervical Cancer in Almost 15 Years
A life-extending treatment for advanced cervical cancer will be made available to hundreds of NHS […]
FLASH Proton Therapy Clinical Trial Begins on Cancers Involving Bones in the Chest
Treatment of the first participant in a clinical trial of FLASH proton therapy for cancers […]
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies
Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]
Phase III RUBY Clinical Trial Shows Jemperli Could Redefine Cancer Treatment
GSK today announced interim results from Part 1 of the RUBY/ENGOT-EN-6-NSGO/GOG3031 phase III trial investigating […]
NHS Slashes Longest Elective and Cancer Patient Waiting Lists
The number of people waiting over 18 months for NHS care has fallen again despite […]
- Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
- NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
- Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
- Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
- Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more